ArticleTranslational andrology and urology2026
A contrast-enhanced ultrasound-based nomogram for preoperative prediction of pseudocapsule status in localized clear cell renal cell carcinoma: a retrospective study.
Article in Translational andrology and urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The pseudocapsule (PC) status of clear cell renal cell carcinoma (ccRCC) is closely associated with tumor aggressiveness and surgical strategy, yet accurate preoperative non-invasive assessment remains challenging. This study aimed to develop and internally validate a contrast-enhanced ultrasound (CEUS)-based prediction model for assessing PC status in patients with ccRCC. Methods: This retrospective study enrolled 254 patients with pathologically confirmed ccRCC who underwent surgery at Shanghai General Hospital, between August 2021 and December 2024. All patients received preoperative conventional ultrasound and CEUS examinations. Independent risk factors for PC absence or penetration were identified using multivariable binary logistic regression analysis. These factors were then incorporated into a nomogram to construct a predictive model. The model's discriminatory performance was assessed by the area under the receiver operating characteristic (ROC) curve (AUC). Internal validation was performed using bootstrap resampling to generate calibration curves and evaluate goodness-of-fit via the Hosmer-Lemeshow test. Finally, the clinical utility of the nomogram was determined using decision curve analysis (DCA). Results: Three CEUS features-incomplete PC sign, peak hypoenhancement, and rapid washout pattern-were independent predictors in the final model. The nomogram showed acceptable discrimination [training AUC: 0.779, 95% confidence interval (CI): 0.692-0.867; validation AUC: 0.749, 95% CI: 0.600-0.898] and calibration (Hosmer-Lemeshow P>0.05). DCA supported its potential clinical utility. Conclusions: In conclusion, a CEUS-based nomogram was developed and internally validated to preoperatively predict PC status in ccRCC. This practical, non-invasive tool can guide and optimize surgical planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.